Preferred Label : PCWG Scher Prostate Cancer 2008 Oncology Response Criteria;
NCIt related terms : PCWG2; PCWG SCHER PROSTATE CANCER 2008;
Alternative definition : CDISC: Design and end points of clinical trials for patients with progressive prostate
cancer and castrate levels of testosterone: recommendations of the Prostate Cancer
Clinical Trials Working Group. (Scher HI, Halabi S, Tannock I, Morris M, Sternberg
CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff
P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M;
Prostate Cancer Clinical Trials Working Group. Design and end points of clinical trials
for patients with progressive prostate cancer and castrate levels of testosterone:
recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol.
2008 Mar 1;26(7):1148-59.);
NCI Metathesaurus CUI : CL504637;
Origin ID : C126038;
UMLS CUI : C4288533;
Semantic type(s)
- concept_is_in_subset
